Ashwath Jayagopal compensation by year
Opus Genetics Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $354,023 | $416,000 |
| Bonus | $50,000 | $50,000 |
| Stock awards | $199,500 | $48,825 |
| Option awards | $477,286 | $33,663 |
| Non-equity incentive | $151,345 | $205,920 |
| Pension and deferred compensation | $0 | $0 |
| All other | $10,000 | $10,440 |
| Total | $1,242,154 | $764,848 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed March 23, 2026, accession 0001140361-26-010757, and prior-year filings.
How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-26-010757. Every figure is read from that document and cited to the page and table it appears in. Filed March 23, 2026.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 75,000 | $89,250 | — |
| Option | 225,000 | — | $2.66 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Opus Genetics’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| George Magrath | Chief Executive Officer | $1,493,383 |
| Ashwath Jayagopal · this page | Chief Scientific and Development Officer | $764,848 |
| Joseph Schachle | Chief Operating Officer | $718,408 |
The full Opus Genetics compensation record
free company briefThis page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Opus Genetics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Opus Genetics's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.